Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

48 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-06-30

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Changes in volumetric hemodynamic parameters and fluid overload (Cardiac Index,Stroke Volume, Thoracic Fluid Content, Systemic Vascular Resistance) were measured using a impedance cardiography (ICG) (CardioScreen 1000 - Haemodynamic Measurement System, Medis. GmbH Ilmenau) beginning 15 min prior to midweek dialysis session and continuous measurement thereafter, with a 15-min period after the termination of hemodialysis. Fluid overload were measured by BCM Monitor Fresenius before hemodialysis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Body Composition Monitor Among Daily Home Dialysis With Low Flow Dialysate

NCT03994133

Chronic Kidney Disease Requiring Chronic Dialysis Hemodialysis, Home Electric Impedance

UNKNOWN

The Effects of Hemodialysis Session on Vascular Stiffness

NCT02443376

Arteriopathic Disease Arterial Calcification Complication of Hemodialysis +1 more

COMPLETED

Adjusting Fluid Removal Based on Blood Volume in Hemodialysis: A Randomized Study

NCT01988181

Intradialytic Hypotension End Stage Renal Failure on Dialysis

COMPLETED NA

Effect of Dialysis Techniques on Blood Pressure and Cardiac Function During Dialysis

NCT03249532

End Stage Renal Disease (ESRD) Hemodialysis Hemodiafiltration +2 more

COMPLETED NA

Body Composition Monitor(BCM) Guided Fluid Management in Maintenance Hemodialysis (MHD) Patients

NCT01509937

End Stage Renal Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Failure on Dialysis Body Fluid Retention Impedance Cardiac Output, Low

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hemodialysis patients

* midweek dialysis session
* patients on maintenance hemodialysis at least 3 months
* stable dry weight
* single-pool Kt/V \>1.4
* no clinical cardiovascular disease during the 6 months preceding entry

CardioScreen 1000 - Haemodynamic Measurement System, Medis

Intervention Type DEVICE

Impedance cardiography (ICG)

BCM- Body Composition Monitor, Fresenius Medical Care

Intervention Type DEVICE

Information about the individual fluid status and the nutritional status.

SCHILLER, BR-102 plus, Ambulatory Blood Pressure Monitoring System

Intervention Type DEVICE

Blood pressure monitoring every 15 min during hemodialysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CardioScreen 1000 - Haemodynamic Measurement System, Medis

Impedance cardiography (ICG)

Intervention Type DEVICE

BCM- Body Composition Monitor, Fresenius Medical Care

Information about the individual fluid status and the nutritional status.

Intervention Type DEVICE

SCHILLER, BR-102 plus, Ambulatory Blood Pressure Monitoring System

Blood pressure monitoring every 15 min during hemodialysis

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* give voluntary consent to participate in the study
* patients on maintenance hemodialysis at least 3 months
* stable dry weight
* single-pool Kt/V \>1.4
* no clinical cardiovascular disease during the 6 months preceding entry